Skip to search formSkip to main contentSkip to account menu

Therapy-Related Myelodysplastic Syndrome

Known as: Therapy Related Myelodysplastic Syndrome, Therapy-Related MDS, t-MDS 
A myelodysplastic syndrome caused by chemotherapy and/or radiotherapy.
National Institutes of Health

Related topics

Related topics

8 relations
Bone MarrowBone marrow stem cellHematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Successful Chemotherapy for a Case of Therapy‐Related ALL with MLL Gene Rearrangement Following Treatment of Breast Cancer
To the Editor: Breast cancer survival rates have improved due to better diagnosis performed on the basis of tumor characteristics… 
2011
2011
Prophylactic oseltamivir treatment for prevention of donor–recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment
Prophylactic oseltamivir treatment for prevention of donor–recipient influenza A H1N1 virus transmission does not compromise stem… 
Review
2011
Review
2011
3q21q26 rearrangements in treatment related leukemia
Review on 3q21q26 rearrangements in treatment related leukemia, with data on clinics, and the genes involved. 
2010
2010
Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients
The prognosis of therapy-related myelodysplastic syndrome and acute leukemia (t-MDS/AL) remains poor. We retrospectively analyzed… 
2005
2005
Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia
Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph… 
2005
2005
Clinical and prognostic characterization of myelodysplastic syndromes
The myelodysplastic syndromes (MDS) provide a clinical model for evaluating the evolution of a relatively indolent malignancy… 
2005
2005
Therapy-related myelodysplasia/ leukemia (t-MDS/AML) following treatment of children with Ewing sarcoma and primitive neuroectodermal tumor of bone (PNET)
8514 Background: Limited information exists regarding risk of t-MDS/AML after Ewing’s sarcoma. Methods: We followed a cohort of… 
2004
2004
A case of refractory anemia with 17p− syndrome following azathioprine treatment for heart transplantation
A case of refractory anemia with 17p− syndrome following azathioprine treatment for heart transplantation 
2003
2003
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex… 
1989
1989
[Impaired superoxide production by neutrophils in myelodysplastic syndrome: correlation with bone marrow karyotype].
Superoxide (O2-) production by neutrophils was examined in 21 patients with myelodysplastic syndrome (MDS), including 13 with…